Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F ROUSSEL

Showing results (261-270 of 306) with videos related to

Pageof 31
Sort By:
Developmental Cell|November 7, 2017
mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and MedulloblastomaChang-Chih Wu, Shirui Hou, Brent A Orr, et al.
Oncogene|December 23, 2014
Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenanceJ C Lindsey, D Kawauchi, E C Schwalbe, et al.
Science Advances|April 15, 2026
Patient-derived pediatric brain tumor orthotopic xenografts and tumor organoids faithfully recapitulate primary tumorsJustin S Williams, Dana M Farmer, Qianqian Li, et al.
Nature Communications|August 11, 2019
MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostatIda Annunziata, Diantha van de Vlekkert, Elmar Wolf, et al.
Gene|March 30, 1999
Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1)S M Bodner, C W Naeve, K M Rakestraw, et al.
Cell Reports|March 23, 2017
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 MedulloblastomaBaoHan T Vo, Chunliang Li, Marc A Morgan, et al.
Cancer Research Communications|November 16, 2023
CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma ActivityDalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, et al.
Nature Communications|June 13, 2015
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modellingMarc Zuckermann, Volker Hovestadt, Christiane B Knobbe-Thomsen, et al.
European Journal of Medicinal Chemistry|March 10, 2023
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitorsMladen Koravovic, Anand Mayasundari, Gordana Tasic, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastomaJingjing Liu, Xu Yang, Mingrui Zhu, et al.
Pageof 31

Showing results (261-270 of 306) with videos related to

Sort By:
Pageof 31
Developmental Cell|November 7, 2017
mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and MedulloblastomaChang-Chih Wu, Shirui Hou, Brent A Orr, et al.
Oncogene|December 23, 2014
Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenanceJ C Lindsey, D Kawauchi, E C Schwalbe, et al.
Science Advances|April 15, 2026
Patient-derived pediatric brain tumor orthotopic xenografts and tumor organoids faithfully recapitulate primary tumorsJustin S Williams, Dana M Farmer, Qianqian Li, et al.
Nature Communications|August 11, 2019
MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostatIda Annunziata, Diantha van de Vlekkert, Elmar Wolf, et al.
Gene|March 30, 1999
Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1)S M Bodner, C W Naeve, K M Rakestraw, et al.
Cell Reports|March 23, 2017
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 MedulloblastomaBaoHan T Vo, Chunliang Li, Marc A Morgan, et al.
Cancer Research Communications|November 16, 2023
CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma ActivityDalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, et al.
Nature Communications|June 13, 2015
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modellingMarc Zuckermann, Volker Hovestadt, Christiane B Knobbe-Thomsen, et al.
European Journal of Medicinal Chemistry|March 10, 2023
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitorsMladen Koravovic, Anand Mayasundari, Gordana Tasic, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastomaJingjing Liu, Xu Yang, Mingrui Zhu, et al.
Pageof 31